ATS: Amgen, AZ say data backs Tezspire’s role in COPD – Pharmaphorum

COPD

Amgen and AstraZeneca have said their severe asthma therapy Tezspire could have a role to play in chronic obstructive pulmonary disease (COPD) – a …

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave